— Creative director and head makeup artist at POPBeauty Sara Strand hosted virtual facials on Zoom to showcase the brand’s 100 percent vegan and cruelty-free skincare products.— Celebrity spray tan artist Sophie Evans hosted virtual tanning appointments on Zoom using a variety of St. Tropez tanning products to get clients ready for Halloween.— Playboy published experts from a previously unpublished transcript from Donald Trump’s interview with the magazine from their October 2004 issue. The interview was conducted in May of 2004 between Trump and Playboy contributor David Hochman in Trump Tower for the publication’s longstanding franchise, The Playboy Interview.Marshmello Courtesy of Mellodees- Advertisement – Celebs were keeping busy this week, from Katharine McPhee, Sarah Hyland, Rebel Wilson and more stars attending Jennifer Klein’s Day of Indulgence, Gratitude and Wellness event, to Megan Thee Stallion hosting a Halloween party in Atlanta, to Addison Rae taking a stroll in L.A. Read on to find out more of what the stars have been up to!— Producer Jennifer Klein hosted a safe and socially distanced Day of Indulgence, Gratitude and Wellness event in L.A. attended by Katharine McPhee, Camila Morrone, Sarah Hyland, Olivia Munn, Allison Janney, Annabelle Wallis, Rebel Wilson and more. At the celebration, McPhee snagged a Radley purse, a Rothy’s reversible tote, Credo’s Exa foundation, a Ggiata sandwich and Garrett Popcorn for husband David Foster. Morrone washed her hands at the Mrs. Meyers hand washing station upon arrival and Hyland and Munn picked out Drunk Elephant and Kinship skincare products. Janney and Wallis, meanwhile, tried out ReVive’s massage eye roller available in stores in spring 2021. Wilson, for her part, browsed the Alo Yoga room and enjoyed an EO neck massage. Cynthia Ervio attended virtually and loved the 54 Thrones’ body butters. Tyra Banks debuted her SMiZE ice cream and sent over the Salty Cream Caramel Queen flavor for guests to try. Attendees also enjoyed HumbleMaker’s coffee shots and core bars, shots of Health-Ade Plus, Recess’ sparkling peach water and Don Julio mini margaritas along with beauty treatments like personalized Pixi glow tonics. Guests took home Don Julio’s harvest spice cocktail kits, boxes of Sugarfina candies, rose gold Samsonite suitcases filled with Jordan Samuel Skin and Therabody beauty products, Eyeko mascara and a personalized LeSportsac tote.- Advertisement – – Advertisement – — Megan Thee Stallion hosted her Hottieween bash sponsored by D’USSE at Allure Nightclub in Atlanta.— Rapper Rico Nasty dropped a limited-edition designer toy in partnership with entertainment company Superplastic inspired by her next album “Nightmare Vacation.”— Cara Santana covered Lapalme Magazine’s Fall 2020 issue and discussed life after losing her dog, love and politics.- Advertisement – — DJ and producer Marshmello promoted his limited-edition lovable plush robot Dee toy from the new kids channel Mellodees available at shop.mellodees.com for $45.— POPBeauty and Thistle teamed up to celebrate National Vegan Month and showcase both brand’s vegan products through a meal delivery and beauty products package.— Addison Rae wore the Bleusalt’s The Cindy Pant, which the brand created with Cindy Crawford, while out and about in L.A.— Alexa PenaVega highlighted Dr. Brandt’s Poredermabrasion as one of her travel essentials in an Instagram post.
Wilder KO’d Ortiz in a come-from-behind victory in their rematch Joshua analysed Wilder’s second knockout of Ortiz: “The good thing he does here, his back’s on the ropes against Ortiz, which is a dangerous place to be because on the ropes there’s no room to create space.“But what he does, he flicks the jab out to make Ortiz think, ‘Hang on a minute, there’s something coming back if I dive in.’“So Ortiz steps back and follows him across. What Wilder does as he’s moving round to get more space, from the ropes he’s moved around, he’s the general in the ring because he’s got all the space behind him.“Now Ortiz’s back is on the ropes, which is a very dangerous place for Ortiz, so Wilder’s done a great thing there to turn the tables.“He’s controlling with the lead hand. Not every jab is going to land, sometimes we just use it as a smokescreen to put something there.“And once that jab touches your hand, your shoulder, your face, I know this bad boy [the right hand] is going to follow.”Wilder’s run would eventually end due to the front-foot aggression of Fury, a different style to the one that Ortiz came so close with. – Advertisement – 1:10 Luis Ortiz may have sighed regretfully at seeing Deontay Wilder trounced by Tyson Fury earlier this year.It was Ortiz who, not once but twice, found himself within touching distance of ending Wilder’s fearsome reign – but on both occasions he succumbed to come-from-behind knockout punches.Now aged 41, Cuba’s heavyweight contender Ortiz is in last-chance saloon and is set to return on Saturday night against Alexander Flores. Wilder sensationally stopped Ortiz in their brilliant first fight Wilder sensationally stopped Ortiz in their brilliant first fight – Advertisement – Ortiz was, particularly from 2016 to 2018, considered to be an avoided and dangerous contender to the world heavyweight championships.Although he had a chance to face Anthony Joshua, promoter Eddie Hearn has said, and twice challenged Wilder, he possessed a reputation as a skilful southpaw that was better left alone.Ortiz’s left hand gave Wilder a shellacking in the seventh round of their first fight in 2018, wobbling the then-unbeaten WBC champion and coming within a whisker of an upset.Wilder said after battling back to end Ortiz’s unbeaten record: “He’s one of the best in the world. Nobody has given Ortiz an opportunity, even after I defeated him.“Normally after you knock somebody out, other guys are willing to fight him because they have seen weakness, chinks in the armour.“They didn’t want to fight Ortiz, they don’t want to fight him now.”
Johnny Depp loses libel case over Sun ‘wife beater’ claim- Advertisement – – Advertisement –
Since her rise to fame in the early aughts, Malin Akerman has been in numerous films. And while you might recognize her best for all of her famous roles like those in 27 Dresses and The Proposal, there’s still so much you don’t know about her. The actress, 42, opened up exclusively to Us Weekly with 25 things about herself — including what her first Hollywood audition was, who the famous hunk she modeled with was before they both made it big and her biggest dreams. Read on to learn more about Friendsgiving star.1. I used to compete nationally in figure skating for 10 years.- Advertisement – 2. My parents always said you have to empty your pockets in order to fill them again. (It has to do with generosity.)3. I have toe thumbs.4. Right before I got The Comeback, I was considering going back to Canada to finish my degree in psychology.- Advertisement – 5. I am a bit color blind when it comes to black, gray and dark blue.6. My first audition in Hollywood was for The Hot Chick, but Rachel McAdams got [the role].7. Rachel and I had worked together prior to that in Canada on Shotgun Love Dolls.Malin Akerman and husband Jack Donnelly. Chris Pizzello/Invision/AP/Shutterstock- Advertisement – 8. I have four tattoos. The one on my left arm is for my son [Sebastian, 7, with ex Roberto Zincone] and my husband [Jack Donnelly].9. My mom was on the Swedish version of Survivor at 70 years old! She’s a true Viking!10. I once pretended to be Catholic so that I could get into my then-boyfriend’s high school. I didn’t want him hanging around all those girls in uniform without me!11. I have a dog but secretly want an owl. My husband won’t let me get one.12. When I moved to L.A., I did a photoshoot for Abercrombie & Fitch with a then-18-year-old Jamie Dornan.13. I love listening to podcasts about cold crime cases.14. The only time I ever tried taking a sleeping pill was on a plane. I woke up on the floor with a flight attendant holding my legs up and calling for an oxygen mask!15. I’m a certified youth and child development coach.16. I am so obsessed with Nutella that I cannot have it in the house.17. One of my favorite movies is Like Water for Chocolate.18. When I was 6, I broke my arm jumping off an old cannon because someone called me a chicken.19. I want to retire in Africa.20. My dream is to go to space. I’m a giant space nerd.21. When we wrapped [2009’s] Watchmen, we played paintball with the whole cast and crew.22. I have been stung by bees and wasps 12 times.23. I have a motorcycle license.24. I love planning birthday parties for others — especially surprises!25. When I first started dating Jack, I dared him to strip for me and my girlfriends poolside because he claimed he had worked as a Chippendales dancer for a summer in England — and he did! That’s when I knew I was going to marry him.Friendsgiving is out in select theaters and available on demand and digital.Listen to Watch With Us to hear more about your favorite shows and for the latest TV news! – Advertisement –
Since early Wednesday morning, when Mr. Trump angrily declared the election to be a “fraud” on the public, he has been mostly ensconced in the Oval Office or the presidential residence, watching television coverage and brooding.Besides his children, he has spoken by phone and at the White House with a coterie of advisers, including the former White House counselor Kellyanne Conway, his campaign manager, Bill Stepien, his deputy campaign manager, Justin Clark, his adviser Hope Hicks, and Ronna McDaniel, the chairwoman of the Republican National Committee.- Advertisement – As he played golf on Saturday, aides said, Mr. Trump was surprisingly calm, given the news he had received upon his arrival. But he had not yet begun to watch television news coverage of Mr. Biden’s victory.Aides cited things they believed Mr. Trump could point to as accomplishments even in defeat, including getting the second-most votes in American history and drawing a new batch of voters into the Republican Party. Vice President Mike Pence spent part of Friday in the Oval Office with Mr. Trump, but the president’s chief of staff, Mark Meadows, who tested positive for the coronavirus the day after the election, has been working remotely on the campaign’s current legal challenges.Mr. Trump’s advisers had succeeded in persuading his personal lawyer Rudolph W. Giuliani to stand down from some of public allegations about fraud. But Mr. Giuliani called Mr. Trump directly to appeal to him, and the president signed off on a news conference outside a landscaping company in Philadelphia that started Saturday morning just after news outlets called the presidential race for Mr. Biden.Some aides were candid with Mr. Trump that there was not much of a path forward, even though they said they would continue on. Only a few had seemed resistant to the idea that Mr. Biden was likely to win, including the president’s son-in-law, Jared Kushner, people who spoke with Mr. Trump said.- Advertisement – – Advertisement –
– Advertisement – Her second chance at romance. Meghan King stumbled upon love again after her split from estranged husband Jim Edmonds — and found a perfect match in boyfriend Christian Schauf.The Real Housewives of Orange County alum was previously married to Edmonds for five years before Us Weekly broke the news in October 2019 that they had called it quits. The former couple share daughter Aspen, born in November 2016, and twin sons Hart and Hayes, born in June 2018.- Advertisement – As she continued to navigate her transition to single motherhood — and balance raising a family with exploring a new relationship — Schauf told the New York Post’s Page Six that he found his new flame’s strength “admirable” when it came to her divorce drama with Edmonds.“This is a 35-year-old woman with three kids under the age of 3 with an ex who is not that easy to deal with — and that is putting it in the nicest way possible — and then having every move you make played out at a scale she does, for her to continue to be positive and push ahead and have goals, and not let it overwhelm her,” he said in July 2020. “It’s really impressive to me.”- Advertisement – After facing a number of ups and downs in her dramatic split from the former St. Louis Cardinals player, King was ready to find The One — again. “I just want to hold somebody’s hand or get a hug and whether or not, in the age of coronavirus or not, as a single woman, I want to be partnered up. I want that relationship,” she said during an episode of her “Intimate Knowledge” podcast in April 2020. “It was never my idea to get divorced and yet here I am and I’m happier than ever now but I do want a partner.”One month later, King’s wish came true. Us confirmed in May 2020 that the former reality TV personality sparked a romance with Schauf, whom she later revealed she met on a dating app.“When I knew I had worked through my pain to the point where it wouldn’t define me or scar me but instead teach me, I knew I was ready to really date,” King wrote in a blog post about her budding romance in June 2020, describing her experience with virtual dating amid the COVID-19 crisis. “I shot for the stars and made a list of every last minute detail of the man I was looking for – my list was pages long – and daily I’d ask God to open my heart to the possibility of loving again.”- Advertisement – Scroll down to look back at King’s sweet relationship with Schauf.
Stacey Cunningham, president of the New York Stock Exchange, speaking at the World Economic Forum in Davos, Switzerland, Jan. 23, 2020.Adam Galasia | CNBC – Advertisement – Regulatory concerns around Chinese listings returned to the public eye last week after the last-minute suspension of Ant Group’s world-record $34.5 billion IPO in Hong Kong and Shanghai.The Shanghai Stock Exchange said Ant Group had reported “significant issues such as the changes in financial technology regulatory environment,” according to a CNBC translation of the statement from Mandarin.Without commenting on this individual case, Cunningham said there was “a lot of dialogue around how Chinese companies list here in the U.S., as well as what Shanghai and Hong Kong are doing.”Cunningham emphasized the importance of retaining the depth and liquidity offered by the U.S. market by balancing investor protections, such as audit oversight, with access, and “not encouraging other companies to go to other global markets.” – Advertisement – “What is really important is that we make sure we are appropriately setting a framework in place that keeps investors protected,” Cunningham said.“We continue to see investor demand for Chinese companies in the U.S. and we haven’t seen that changing yet, despite the fact that there is a lot of talk about trade and about oversight, so we are working constructively and we are optimistic that we will be able to find a way to actually enhance the level of protections that exist on companies here in the U.S.”Half of cross-border initial public offerings in the U.S. in the first nine months of the year came from China, according to Ernst & Young, despite the Senate in May passing a bill that could delist a number of Chinese companies from American exchanges.Ant Group and the regulation question- Advertisement – The New York Stock Exchange (NYSE) is still seeing demand from Chinese companies looking to list in the U.S. despite highly publicized regulatory concerns, its president has told CNBC.Relations between Washington and Beijing have become increasingly fractious in recent years, with President Donald Trump’s administration pushing to reduce domestic financial ties with the world’s second-largest economy.Speaking to CNBC’s Karen Tso on Tuesday night, NYSE President Stacey Cunningham said the exchange was continuing to see demand from Chinese companies for U.S. stock market listings.- Advertisement –
Dec 17, 2004 (CIDRAP News) – To keep influenza vaccine from going to waste, the government announced today that more people will be eligible to receive flu shots starting Jan 3 where supplies are adequate.The Centers for Disease Control and Prevention (CDC) said people aged 50 to 64 and those who care for or share a household with people in high-risk groups will be included in vaccination priority groups as of Jan 3, provided local health authorities determine that the vaccine supply is sufficient.The change was recommended by the CDC’s Advisory Committee on Immunization Practices (ACIP).”In most communities we’re still targeting vaccine to the people in the highest priority groups,” said CDC Director Julie Gerberding, MD. “The challenge is that in some places, health departments and private providers currently do not have enough demand from people in those priority groups. We don’t want those doses to go to waste, so some states are expanding to make good use of those doses. The ACIP’s recommendation is consistent with this approach.”Because of the flu vaccine shortage, the CDC previously had recommended that doses be reserved for children aged 6 to 23 months, people 65 and older, the chronically ill, pregnant women, nursing-home and long-term care residents, children on chronic aspirin therapy, healthcare workers involved in direct patient care, and caregivers and household contacts of babies under 6 months old.The ACIP suggested implementing the change Jan 3 to allow time for unvaccinated people in current priority groups to seek shots.The ACIP also passed a resolution expanding the groups eligible to receive flu shots under the Vaccines for Children (VFC) program, the CDC said. Effective immediately, VFC-eligible children who are household contacts of people in high-risk groups are eligible for vaccination, the committee said.Today’s announcement was foreshadowed last week, when the CDC suggested that the vaccination guidelines could be broadened in states that still had vaccine doses left in the private sector after meeting the demand from priority groups.
Of the 286 postal facilities tested, 23 tested positive. For two of the 23in West Palm Beach, Fla., and Wallingford, Conn.the first tests were negative but later tests turned positive. The Wallingford facility didn’t test positive until the fourth round of testing. In another building, in West Trenton, N.J., no anthrax was found in three rounds of tests, even though a worker had contracted cutaneous anthrax. The GAO puts the bottom line thus: “Because the agencies did not use an empirical process to validate their testing methods, the agencies had limited information available for reliably choosing one method over another and no information on the detection limit to use when evaluating negative results.” The agencies used any of four different preliminary tests and three confirmatory tests to identify anthrax in extracted samples. The number of different tests used, in combination with differences at other stages of the sampling process, increases the level of uncertainty about the results, the GAO contends. Rhodes’s prepared testimony summarizing the GAO reporthttp://www.gao.gov/new.items/d05493t.pdf For its evaluation, the GAO broke the agencies’ sampling activities down into five steps: sampling strategy (where and how many samples were gathered), sample collection methods, sample transportation, sample extraction in the lab, and sample analysis. The agencies mostly used processing solutions to extract samples from dry swabs and get them onto plates for culturing, though in some cases they brought dry swabs into direct contact with plates. Either way, the GAO says, “definitive scientific information regarding extraction efficiency is lacking,” casting additional doubt on the reliability of negative results. The GAO’s conclusion is based on an examination of the approaches used by three agenciesthe US Postal Service (USPS), the Environmental Protection Agency (EPA), and the Centers for Disease Control and Prevention (CDC)to hunt for anthrax in 286 postal facilities after the anthrax mailings in 2001. The report also finds fault with the methods used to gather samples. In most cases the agencies used dry swabs on surfaces, though they also used some moistened swabs, wet wipes, HEPA (high-efficiency particulate air filter) vacuuming, and air samples. None of the collection methods were tested in advance, so the agencies “had no information available for reliably choosing one method over another and no information on the limits of detection to use when evaluating negative results,” the report states. In shipping their samples, the agencies followed regulations designed mainly to prevent leaks and protect workers. The GAO complains that the regulations did not address the matter of protecting the samples from extreme temperatures or other factors that could compromise their biological integrity and lead to false-negative test results. “The sampling strategy used by the agencies could not provide any statistical confidence with regard to the basic question: Is this building contaminated?” the report says. “The lack of validation of agencies’ activities, coupled with limitations associated with their targeted sampling strategy, means that negative results may not be reliable,” the report says. It recommends that the secretary of homeland security take on the task of ensuring that pathogen detection methods are validated and coordinating environmental testing for pathogens by different agencies. The agencies mainly used a targeted sampling strategy, collecting samples mostly from areas they judged likeliest to be contaminated. The GAO takes issue with this approach, saying the agencies should have done probability sampling to achieve “wide-area coverage” and provide statistical confidence in negative results. See also: “None of the agencies’ activities to detect anthrax contamination in the postal facilities were validated,” the GAO said in prepared congressional testimony based on the report. Apr 18, 2005 (CIDRAP News) The Government Accountability Office (GAO) says federal agencies may not be able to reliably rule out the presence of anthrax contamination in a building because their sampling and detection methods have not been adequately tested. The agencies have made some changes in their procedures on the basis of lessons learned from the 2001 attacks and have funded some new research. But these efforts, though important, “do not address the issue of validating all activities related to sampling,” in the GAO’s view. The GAO recommends that the secretary of the Department of Homeland Security (DHS) lead an effort to develop a definition of validation and to ensure that the whole set of sampling activities is validated. That should include studies to “develop probability-based sampling strategies that take into account the complexities of indoor environments.” Also, the DHS chief should coordinate the activities of agencies with expertise in environmental testing. However, DHS officials took exception to the role the GAO recommends for their department. DHS maintained that the EPA has “the primary responsibility of establishing the strategies, guidelines and plans for the recovery from a biological attack, while HHS [the Department of Health and Human Services] has the lead role for any related public health response and guidelines,” the final report states. DHS promised to “coordinate with EPA to ensure appropriate investments are made to explore improved sampling.” When they read a draft of the report, the CDC, USPS, and DHS all agreed that the methods for detecting anthrax were not validated and that a systematic validation effort is needed, the report states. The GAOCongress’s investigative agencyprepared its report for the House Government Reform Subcommittee on National Security, Emerging Threats, and International Relations. GAO staff member Keith A. Rhodes gave a 19-page summary of the 119-page report in testimony prepared for delivery to the committee on Apr 5. Full report “Anthrax Detection: Agencies Need to Validate Sampling Activities in Order to Increase Confidence in Negative Results”http://www.gao.gov/new.items/d05251.pdf
See also: The $14.4 million award to Iomai is intended to support completion of phase 1 clinical trials of a candidate vaccine with adjuvant, according to HHS. The company “may receive an additional $114 million in funding upon successful completion of the phase 1 trials.” The Novartis contract will help the company bring its MF59 adjuvant, used in seasonal flu vaccines for elderly people in Europe, to the United States, the company said. Iomai will use the funds to develop an adjuvant skin patch to be used with flu vaccines, while a GSK news release said only that the money would be used for an “innovative adjuvant technology.” GSK will use the HHS contract to conduct “research and development leading towards licensure of antigen-sparing prepandemic and pandemic vaccines with adjuvant” to protect more people, according to a company statement. The contract gives HHS the option to provide another $44 million for “future clinical development programs” for antigen-sparing vaccines, the company said. Hall said the company’s H5N1 vaccine is egg-based. In July 2006 GSK reported that in a clinical trial, an H5N1 vaccine coupled with the company’s adjuvant triggered a good immune response with only 3.8 micrograms (mcg) of antigen, as compared with 15 mcg of antigen in a typical dose of seasonal flu vaccine (for one flu strain). As noted in today’s HHS statement, early trials of the (unadjuvanted) H5N1 vaccine in the current stockpile showed that it took two 90-mcg doses to induce what was considered a protective immune response. The patch is applied to the skin over the site of vaccination, the company said. “Once the patch is applied, the adjuvant passes into the skin, targeting cells called Langerhans cells. Those specialized skin cells carry the adjuvant to the lymph nodes, where it works to boost an individual’s immune response to the vaccine.” The Department of Health and Human Services (HHS) awarded a 5-year, $63.3 million contract to British-based GlaxoSmithKline (GSK) and a 5-year, $54.8 million contract to Swiss-based Novartis. In addition, Iomai Corp., Gaithersburg, Md., received a $14.4 million, 15-month contract, which could lead to an additional $114 million award, HHS announced in a news release. The aim of the contracts, HHS said, is to put each company in a position to produce, within 6 months after the emergence of a flu pandemic, either 150 million doses of an adjuvant-based pandemic vaccine or enough adjuvant for 150 million doses of such a vaccine. “The contracts also require each company to provide its proprietary adjuvant for U.S. Government–sponsored, independent evaluation with influenza vaccines from other manufacturers,” HHS said. “If we actually had licensed cell-based vaccines with an immunogenic adjuvant, it would put us in a much better position in the US to respond to pandemic influenza,” Osterholm said. The Novartis vaccine Fluad, which contains MF59, is licensed in Europe for preventing seasonal flu in people aged 65 and older, the company said. It said many studies have shown that the vaccine induced stronger antibody responses in elderly people than were seen with an unadjuvanted vaccine. In a news release, Novartis officials said their contract will be used to test the safety and effectiveness of the MF59 adjuvant in a pandemic flu vaccine and to support work on an MF59 production facility in Holly Springs, N.C. The vaccine will be grown in cell culture rather than in eggs. In May 2006 the company received an HHS contract to develop a cell-culture-based flu vaccine and a manufacturing facility for it. Jan 17 HHS news releasehttp://www.hhs.gov/news/press/2007pres/01/20070117b.html Jan 17 Novartis news releasehttp://cws.huginonline.com/N/134323/PR/200701/1098644_5.html With current technology, it would take about 6 months to start producing a vaccine well matched to the pandemic strain, HHS spokesman Bill Hall noted. “By having an adjuvant you can rapidly extend the number of people you can cover early on with vaccine,” he told CIDRAP News. Jan 17, 2007 (CIDRAP News) – In an effort to stretch the nation’s supply of vaccines for a potential influenza pandemic, federal health officials today announced contracts totaling $132.5 million to help three companies develop dose-sparing substances, or adjuvants, to be used with H5N1 flu vaccines. He also expressed gratification that the Novartis contract will support development of a cell-based vaccine. Cell-based production “will definitely shave time off the production of the [pandemic] vaccine,” although the pandemic strain will have to be identified first, he said. Nov 20, 2006, CIDRAP News story “HHS awards 3 contracts for more H5N1 vaccine” Michael T. Osterholm, PhD, MPH, director of the University of Minnesota Center for Infectious Disease Research and Policy, publisher of the CIDRAP Web site, praised HHS for awarding the contracts. “Adjuvants likely will play an important role in extending the number of doses that will be available once a pandemic strain is identified and vaccine production begins,” he said. Novartis said several published studies have indicated that MF59 may reduce the amount of antigen needed in H5N1 vaccines and may help such vaccines provide cross-protection against slightly different, or “drifted,” strains of the virus. An Iomai news release said the additional funding is the estimated amount needed to bring the combination of vaccine and dose-sparing patch to licensure. If the H5N1 avian flu virus evolves into a pandemic strain, vaccines are expected to be in extremely short supply. HHS is stockpiling H5N1 vaccines, but in November the stockpile amounted to enough for only about 3 million people. And no one knows how effective the vaccines will be against an emerging pandemic strain. Hence HHS is funding efforts to make vaccine supplies stretch further and to produce vaccines faster than with the conventional method of growing them in chicken eggs. Jul 26, 2006, CIDRAP News story “Glaxo says its H5N1 vaccine works at low dose”